Effect of perioperative antioxidant therapy on suboptimal islet transplantation in rats

M. L. Brown, M. Braun, Luca Cicalese, Cristiana Rastellini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Islet transplantation success is limited by the posttransplant inflammatory response, and we are investigating the ability of antioxidants to neutralize this islet damage. We have shown that pyruvate can enhance the engraftment and functionality of a suboptimal islet mass in rats. The present study further investigated the effects of pyruvate, as well as the antioxidants vitamin E and vitamin C. In study A, 350 syngeneic islets were transplanted into the liver of chemically diabetic rats. Antioxidant treatment, or vehicle, was administered during the perioperative period and an intraperitoneal glucose tolerance test (IPGTT) was performed 2 months posttransplant. In study B, 500 syngeneic islets were transplanted under the kidney capsule of chemically diabetic rats. Antioxidant treatment was administered during the perioperative period. Islet-bearing kidney grafts were harvested 24, 48, and 96 hours posttransplant for histological study. Results revealed that pyruvate was the only significantly effective treatment in enhancing the engraftment and functionality of a suboptimal islet mass. Respectively, 56% and 80% of pyruvate-treated rats became normoglycemic after islet transplantation in study A and study B and had a normal insulin response to IPGTT. Histology results from the islet-bearing kidneys were inconclusive as to whether or not pyruvate has an antiapoptotic effect. We conclude that pyruvate, but not vitamin E or vitamin C, aids in the engraftment and functionality of a suboptimal islet mass with as much effectiveness as a full mass in this study. Further investigation into the mechanism of pyruvate protection is still warranted.

Original languageEnglish (US)
Pages (from-to)217-219
Number of pages3
JournalTransplantation Proceedings
Volume37
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Islets of Langerhans Transplantation
Pyruvic Acid
Antioxidants
Perioperative Period
Glucose Tolerance Test
Vitamin E
Kidney
Therapeutics
Ascorbic Acid
Capsules
Histology
Insulin
Transplants
Liver

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Effect of perioperative antioxidant therapy on suboptimal islet transplantation in rats. / Brown, M. L.; Braun, M.; Cicalese, Luca; Rastellini, Cristiana.

In: Transplantation Proceedings, Vol. 37, No. 1, 01.2005, p. 217-219.

Research output: Contribution to journalArticle

Brown, M. L. ; Braun, M. ; Cicalese, Luca ; Rastellini, Cristiana. / Effect of perioperative antioxidant therapy on suboptimal islet transplantation in rats. In: Transplantation Proceedings. 2005 ; Vol. 37, No. 1. pp. 217-219.
@article{6f93d0b93e3c4008820f6a195ebff228,
title = "Effect of perioperative antioxidant therapy on suboptimal islet transplantation in rats",
abstract = "Islet transplantation success is limited by the posttransplant inflammatory response, and we are investigating the ability of antioxidants to neutralize this islet damage. We have shown that pyruvate can enhance the engraftment and functionality of a suboptimal islet mass in rats. The present study further investigated the effects of pyruvate, as well as the antioxidants vitamin E and vitamin C. In study A, 350 syngeneic islets were transplanted into the liver of chemically diabetic rats. Antioxidant treatment, or vehicle, was administered during the perioperative period and an intraperitoneal glucose tolerance test (IPGTT) was performed 2 months posttransplant. In study B, 500 syngeneic islets were transplanted under the kidney capsule of chemically diabetic rats. Antioxidant treatment was administered during the perioperative period. Islet-bearing kidney grafts were harvested 24, 48, and 96 hours posttransplant for histological study. Results revealed that pyruvate was the only significantly effective treatment in enhancing the engraftment and functionality of a suboptimal islet mass. Respectively, 56{\%} and 80{\%} of pyruvate-treated rats became normoglycemic after islet transplantation in study A and study B and had a normal insulin response to IPGTT. Histology results from the islet-bearing kidneys were inconclusive as to whether or not pyruvate has an antiapoptotic effect. We conclude that pyruvate, but not vitamin E or vitamin C, aids in the engraftment and functionality of a suboptimal islet mass with as much effectiveness as a full mass in this study. Further investigation into the mechanism of pyruvate protection is still warranted.",
author = "Brown, {M. L.} and M. Braun and Luca Cicalese and Cristiana Rastellini",
year = "2005",
month = "1",
doi = "10.1016/j.transproceed.2004.11.019",
language = "English (US)",
volume = "37",
pages = "217--219",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Effect of perioperative antioxidant therapy on suboptimal islet transplantation in rats

AU - Brown, M. L.

AU - Braun, M.

AU - Cicalese, Luca

AU - Rastellini, Cristiana

PY - 2005/1

Y1 - 2005/1

N2 - Islet transplantation success is limited by the posttransplant inflammatory response, and we are investigating the ability of antioxidants to neutralize this islet damage. We have shown that pyruvate can enhance the engraftment and functionality of a suboptimal islet mass in rats. The present study further investigated the effects of pyruvate, as well as the antioxidants vitamin E and vitamin C. In study A, 350 syngeneic islets were transplanted into the liver of chemically diabetic rats. Antioxidant treatment, or vehicle, was administered during the perioperative period and an intraperitoneal glucose tolerance test (IPGTT) was performed 2 months posttransplant. In study B, 500 syngeneic islets were transplanted under the kidney capsule of chemically diabetic rats. Antioxidant treatment was administered during the perioperative period. Islet-bearing kidney grafts were harvested 24, 48, and 96 hours posttransplant for histological study. Results revealed that pyruvate was the only significantly effective treatment in enhancing the engraftment and functionality of a suboptimal islet mass. Respectively, 56% and 80% of pyruvate-treated rats became normoglycemic after islet transplantation in study A and study B and had a normal insulin response to IPGTT. Histology results from the islet-bearing kidneys were inconclusive as to whether or not pyruvate has an antiapoptotic effect. We conclude that pyruvate, but not vitamin E or vitamin C, aids in the engraftment and functionality of a suboptimal islet mass with as much effectiveness as a full mass in this study. Further investigation into the mechanism of pyruvate protection is still warranted.

AB - Islet transplantation success is limited by the posttransplant inflammatory response, and we are investigating the ability of antioxidants to neutralize this islet damage. We have shown that pyruvate can enhance the engraftment and functionality of a suboptimal islet mass in rats. The present study further investigated the effects of pyruvate, as well as the antioxidants vitamin E and vitamin C. In study A, 350 syngeneic islets were transplanted into the liver of chemically diabetic rats. Antioxidant treatment, or vehicle, was administered during the perioperative period and an intraperitoneal glucose tolerance test (IPGTT) was performed 2 months posttransplant. In study B, 500 syngeneic islets were transplanted under the kidney capsule of chemically diabetic rats. Antioxidant treatment was administered during the perioperative period. Islet-bearing kidney grafts were harvested 24, 48, and 96 hours posttransplant for histological study. Results revealed that pyruvate was the only significantly effective treatment in enhancing the engraftment and functionality of a suboptimal islet mass. Respectively, 56% and 80% of pyruvate-treated rats became normoglycemic after islet transplantation in study A and study B and had a normal insulin response to IPGTT. Histology results from the islet-bearing kidneys were inconclusive as to whether or not pyruvate has an antiapoptotic effect. We conclude that pyruvate, but not vitamin E or vitamin C, aids in the engraftment and functionality of a suboptimal islet mass with as much effectiveness as a full mass in this study. Further investigation into the mechanism of pyruvate protection is still warranted.

UR - http://www.scopus.com/inward/record.url?scp=16244421089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16244421089&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.11.019

DO - 10.1016/j.transproceed.2004.11.019

M3 - Article

C2 - 15808599

AN - SCOPUS:16244421089

VL - 37

SP - 217

EP - 219

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 1

ER -